## Abstract Genetic events underlying the pathogenesis of breast cancer have been studied extensively and several clinically significant markers have been identified. For example, amplification and overexpression of the __ERBB2__ oncogene is associated with poor prognosis in breast cancer and __ERB
Amplification and overexpression of prosaposin in prostate cancer
✍ Scribed by Shahriar Koochekpour; Yu-Jun Zhuang; Rameen Beroukhim; Chia-Ling Hsieh; Matthias D. Hofer; Haiyen E. Zhau; Masao Hiraiwa; Daniel Y. Pattan; Joy L. Ware; Ronald B. Luftig; Konrad Sandhoff; Charles L. Sawyers; Kenneth J. Pienta; Mark A. Rubin; Robert L. Vessella; William R. Sellers; Oliver Sartor
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 290 KB
- Volume
- 44
- Category
- Article
- ISSN
- 1045-2257
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
We identified prosaposin (PSAP) as a secreted protein expressed in androgen‐independent (AI) prostate cancer cells by cloning/sequencing, after probing a PC‐3 cDNA library expressed in the λTriplEx phagemid expression vector with a polyclonal rabbit antibody generated against pooled human seminal plasma. PSAP is a neurotrophic molecule; its deficiency or inactivation has proved to be lethal in man and mice, and in mice, it leads to abnormal development and atrophy of the prostate gland, despite normal testosterone levels. We used Southern hybridization, quantitative real‐time polymerase chain reaction, and/or single nucleotide polymorphism (SNP) array analysis, and we now report the genomic amplification of PSAP in the metastatic AI prostate cancer cell lines, PC‐3, DU‐145, MDA‐PCa 2b, M‐12, and NCI‐H660. In addition, by using SNP arrays and a set of 25 punch biopsy samples of human prostate cancer xenografts (LAPC3, LuCaP 23.1, 35, 49, 58, 73, 77, 81, 86.2, 92.1, 93, 96, 105, and 115), lymph nodes, and visceral‐organ metastases, we detected amplification of the PSAP locus (10q22.1) in LuCaP 58 and 96 xenografts and two lymph node metastases. In addition, AI metastatic prostate cancer cell lines C4‐2B and IA8‐ARCaP over‐expressed PSAP mRNA without evidence of genomic amplification. Taken together with prior data that demonstrated the growth‐, migration‐, and invasion‐promoting activities, the activation of multiple signal transduction pathways, and the antiapoptotic effect of PSAP (or one of its active domains, saposin C) in prostate cancer cells, our current observation of PSAP amplification or overexpression in prostate cancer suggests, for the first time, a role for this molecule in the process of carcinogenesis or cancer progression in the prostate. © 2005 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract Androgen‐regulated genes (ARG) are implicated in normal and neoplastic growth of the prostate. Recently, we reported genomic amplification and/or overexpression of a previously known neurotrophic factor, prosaposin, in androgen‐independent (AI) or metastatic prostate cancer (PCa) cells
Gain of chromosome arm 8q is a frequent genetic alteration in breast and prostate cancer. Two amplified subregions, 8q21 and 8q23-24, have been identified with comparative genomic hybridization (CGH). We have recently demonstrated that the EIF3S3 (eIF3-p40) gene, located at 8q23, is often amplified
## Abstract Identification of genes selectively expressed in tumors or individual tissues is a crucial prerequisite for molecular diagnosis and treatment of cancer by addressing molecular targets. By screening an expression database, we identified the novel gene __D__‐__PCa__‐__2__ (Dresden prostat
Cyclins and their associated kinases (cdks) play a key role in controlling the cell cycle, a process whose disregulation can potentially lead to uncontrolled cell growth and hence to cancer. We have studied the role of both cyclin E and its associated kinase cdk2 in ovarian cancer. Primary, metastat
The authors thank Liisa Kaarela, Helmi Konola, and Mirja Ma ¨kela ¨inen for their expert technical assistance and Risto Bloigu for helping with the statistical analysis.